News
-
-
PRESS RELEASE
Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease
Telomir Pharmaceuticals announces promising findings from copper binding studies with Telomir-1, addressing Wilson's disease and metal toxicity. Telomir-1 shows potential in preclinical models for multiple conditions -
PRESS RELEASE
South Star Battery Metals Announces Upsize of Non-Brokered Private Placement to Raise Up to US$3.20M, Extends Closing and Amended and Restated Stream Agreement
South Star Battery Metals Corp. increases Private Placement size to US$3.2 million. Proceeds to be used for exploration, development, and working capital. Amends Stream Agreement with Sprott Private Resource Streaming and Royalty Corp -
-
PRESS RELEASE
Brightline Interactive Successfully Delivers A Scalable Immersive Simulation To A Global Government Service Integrator, Positioning Itself As A Leading Operating System For Processing And Visualizing Complex Information In 3D Space
Glimpse Group's subsidiary, Brightline Interactive, delivers advanced spatial simulation using SpatialCore to a government services integrator, showcasing potential in spatial computing and AI -
PRESS RELEASE
Alset AI Broadens Investment Policy to Embrace Decentralized AI, Quantum AI, Quantum Computing, and Cryptocurrency Opportunities
Alset AI Ventures Inc. updates investment policy to include decentralized AI, quantum AI, quantum computing, and cryptocurrency opportunities. Focus on innovation through strategic investments and cloud solutions -
-
PRESS RELEASE
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone
Zomedica launches two new assays for TRUFORMA Platform - canine NT-proBNP and progesterone tests for dogs. These assays provide precise in-clinic results for cardiac and reproductive conditions -
PRESS RELEASE
NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape
NanoViricides, Inc. announces that its antiviral drug candidate NV-387 shows promise in combating potential bird flu pandemic. The drug mimics essential host-side features, making it hard for the virus to escape -
